Drug-Coated Balloons in Small Vessels: Preferred Strategy to Drug-Eluting Stents?
- PMID: 37164604
- DOI: 10.1016/j.jcin.2023.03.005
Drug-Coated Balloons in Small Vessels: Preferred Strategy to Drug-Eluting Stents?
Keywords: coronary artery disease; drug-coated balloon; drug-eluting balloon; percutaneous coronary intervention; small vessel disease.
Conflict of interest statement
Funding Support and Author Disclosures Dr Abbott has received consulting fees from Abbott, Penumbra, Philips, Rapid AI, and Shockwave; has received institutional research grants from Boston Scientific and Microport; and has served on advisory boards for Medtronic and Philips. Dr Wykrzykowska has received an institutional research grant from Medtronic; institutional speaker fees from Boston Scientific and Sinomed. Dr Lenselink has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels: PICCOLETO-II 3-Year Follow-Up.JACC Cardiovasc Interv. 2023 May 8;16(9):1054-1061. doi: 10.1016/j.jcin.2023.02.011. Epub 2023 Apr 19. JACC Cardiovasc Interv. 2023. PMID: 37164603 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
